Research ExplorerPublicationsZerebrotendinöse Xanthomatose-eine behandelbare Stoffwechsel...

Zerebrotendinöse Xanthomatose-eine behandelbare Stoffwechselerkrankung

Standard

Zerebrotendinöse Xanthomatose-eine behandelbare Stoffwechselerkrankung. / Sperhake, J P; Matschke, J.

In: NERVENARZT, Vol. 75, No. 6, 01.06.2004, p. 608.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Sperhake, JP & Matschke, J 2004, 'Zerebrotendinöse Xanthomatose-eine behandelbare Stoffwechselerkrankung', NERVENARZT, vol. 75, no. 6, pp. 608. https://doi.org/10.1007/s00115-003-1500-y

APA

Sperhake, J. P., & Matschke, J. (2004). Zerebrotendinöse Xanthomatose-eine behandelbare Stoffwechselerkrankung. NERVENARZT, 75(6), 608. https://doi.org/10.1007/s00115-003-1500-y

Vancouver

Sperhake JP, Matschke J. Zerebrotendinöse Xanthomatose-eine behandelbare Stoffwechselerkrankung. NERVENARZT. 2004 Jun 1;75(6):608. https://doi.org/10.1007/s00115-003-1500-y

Bibtex

@article{4081ebd27cd8489aa9cbe84b982b8f2e,
title = "Zerebrotendin{\"o}se Xanthomatose-eine behandelbare Stoffwechselerkrankung",
keywords = "Adult, Brain, Chenodeoxycholic Acid, Cholestanol, Cholesterol, Chromosome Aberrations, Diagnosis, Differential, Female, Follow-Up Studies, Genes, Recessive, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neurologic Examination, Steroid Hydroxylases, Treatment Outcome, Triglycerides, Xanthomatosis, Cerebrotendinous",
author = "Sperhake, {J P} and J Matschke",
year = "2004",
month = jun,
day = "1",
doi = "10.1007/s00115-003-1500-y",
language = "Deutsch",
volume = "75",
pages = "608",
journal = "NERVENARZT",
issn = "0028-2804",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - Zerebrotendinöse Xanthomatose-eine behandelbare Stoffwechselerkrankung

AU - Sperhake, J P

AU - Matschke, J

PY - 2004/6/1

Y1 - 2004/6/1

KW - Adult

KW - Brain

KW - Chenodeoxycholic Acid

KW - Cholestanol

KW - Cholesterol

KW - Chromosome Aberrations

KW - Diagnosis, Differential

KW - Female

KW - Follow-Up Studies

KW - Genes, Recessive

KW - Humans

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Neurologic Examination

KW - Steroid Hydroxylases

KW - Treatment Outcome

KW - Triglycerides

KW - Xanthomatosis, Cerebrotendinous

U2 - 10.1007/s00115-003-1500-y

DO - 10.1007/s00115-003-1500-y

M3 - SCORING: Zeitschriftenaufsatz

C2 - 15257383

VL - 75

SP - 608

JO - NERVENARZT

JF - NERVENARZT

SN - 0028-2804

IS - 6

ER -